MODAG GmbH   Report issue

For profit Phase 1
Founded: Wendelsheim Germany (2013)

Organization Overview

First Clinical Trial
2019
NCT04208152
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

MODAG GmbH